Cargando…
The Efficacy of Using Patient-Derived Organoids to Predict Treatment Response in Colorectal Cancer
SIMPLE SUMMARY: Colorectal cancer is the third most commonly diagnosed cancer. Patients may receive chemotherapy, targeted therapy, immunotherapy, radiotherapy, and/or surgery. However, not all patients will benefit from each available treatment option. There has been rising interest in personalised...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913532/ https://www.ncbi.nlm.nih.gov/pubmed/36765763 http://dx.doi.org/10.3390/cancers15030805 |